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INTRODUCTION
Children of today are citizens of tomorrow and upon them 
depend the weal and welfare of the community. In a country like 
India,  children  fall  an easy  prey  to  anemia as  majority  of  them 
remain ill-fed, ill-clothed and undernourished due to poverty and 
ignorance. If not detected at the earliest point of time, this  disease 
which is draconian will spread it’s tentacles so widely as to impair 
or endanger the very physical condition of the children.
Among  the  haematological  disorders,  anemia  is  the 
commonest entity of multiple aetiologies. The meaning of Greek 
word “anemia” is without blood.
It is a major world health problem and is an important cause 
of morbidity and mortality much of which can be preventable. Man 
has only partially adapted to the rapid growth in human population 
and  environmental  changes  and  anemia  is  one  of  the  effects  of 
these  factors.  Thus  still  the  most  common  cause  of  anemia  in 
children  is  related  to  nutritional  deficiency  especially  iron 
deficiency. Initially man depend mostly on animal food and as he 
learned  agricultural  practices,  the  contribution  of  animal  food 
reduced drastically to less than 5%. This profoundly affected the 
bioavailable  iron  and  folate  resulting  in  nutritional  deficiency 
anemia.
Anemia  is  defined  as  the  reduction  of  RBC  volume  or 
hemoglobin concentration below the range of values for a particular 
age and sex.
The  detection  and  diagnosis  of  anemia  are  frequently  the 
focus  of  attention  in  the  care  of  patients  because  accurate 
quantification and rational analysis of problem is must.
Anemia is not a diagnosis in itself like fever but merely is an 
objective sign of the presence of disease.  The correct diagnostic 
terminology  for  a  child  with  anemia  requires  the  detection  of 
etiology, pathology and pathogenesis of the anemia.
A  systematic  approach  through  proper  history,  physical 
examination  and  relevant  investigations  are  very  essential  to 
diagnose the various causes of anemia.
This  study   have  evaluated  the  clinical  profile  of 
hypochromic microcytic anemia among the children. In the recent 
era various newer diagnostic modalities are available to findout the 
cause of anemia. But most of them are out of reach of the hands of 
the children of  lower socioeconomic status. Nutritional deficiency 
anemia  particularly  iron  deficiency anemia  is  the  most  common 
type of anemia among these children. 
In countries like India iron deficiency anemia coexists with 
other types of anemia in almost every child with anemia. This iron 
deficiency  masks  the  underlying  diseases  especially  thalassemia 
trait which cannot be diagnosed even by higher investigations like 
Hb electrophoresis unless the iron deficiency is corrected prior to 
the  electrophoresis.  Though  thalassemia  trait  cases   can  lead  a 
normal  life,  unless  they  are  identified  and  genetic  counselling 
given,they  will  transmit  the  gene  to  next  generation  leading  to 
future  thalassemia  major  cases  which  is  a  major  burden  to  the 
family as well as the society, which is a preventable one.  
Beta thalassemia is the most common single gene disorder in 
our  country.  Beta  thalassemia  major  is  a  homozygous  severe 
transfusion dependent condition with most of the children dying in 
childhood. Beta thalassemia trait is a heterozygous genetic disorder 
having  normal  growth  and  development  and  individual  may 
occasionally have mild anemia
To prevent the birth of a homozygous child, the best option is 
identification  of  carrier  state,  which  is  a  valid  alternative  to 
managing  thalassemic  mojor  children.  This  disease  is  a  prime 
example in which prevention has primary importance and priority 
over treatment, thus prenatal diagnosis has been the main stay of 
most  control  programmes.  As  with  any  autosomal  recessive 
disorder,  the  incidence  of  the  homozygote  can be  decreased,  by 
detection of a carrier state.
With the consideration of all the above problems started this 
study   is  undertaken  to  formulate  an  approach  to  hypochromic 
microcytic anemia in children which is easy, feasible, cost effective 
and can be followed in resource poor settings. Even it is  the ideal 
approach to all cases of hypochromic microcytic anemia inorder to 
overcome the above problems and to find out the exact cause of 
hypochromic microcytic RBC’s.
                    REVIEW OF LITERATURE
Historical aspects:
The basic concepts of hematology came largely from internal 
medicine and from the experimental sciences. Every paediatrician, 
particularly  haematologists,  must  remember  the  names  such  as 
Ehrlich,  Metchnikoff,  Landsteiner,  Chauffard,  Downey,  Minot, 
Castle, Whipple and Wintrobe  who have pioneered in hematology.
Traditionally,  the  history  of   anemia  began  in  1889  with  Von 
Jaksh’s  report  on  the  condition  that  bears  his  name  which  he 
designated pseudo leucaemica infantum 53,54
In 1919,Winifred Ashby measured the  normal  life  span of 
RBC’s of adult using the differential agglutination60
More  lasting  and  far  more  important  was  the  contribution 
made to paediatric hematology by Thomas.B.Cooley in 1925 when 
he salvaged a distinct entity now known as thalassemia 55
In  1927,Heinrich  Baar  wrote,  “The  hemoglobin  content 
suffers more than the RBC count” in anemia.
George  Guest  conducted  meticulous  studies  between  1932 
and 1942 with regards to Hb levels, RBC, Packed cell volumes of a 
large group of infants and young children and showed convincingly 
that  a  fall  in  the  mean  corpuscular  hemoglobin  (MCV)  in  the 
presence  of seemingly adequate Hb levels could be normalised by 
administration of  Iron and was the first  person to observe iron 
deficiency anemia of infancy.
In  1944,  Blackfan  and  diamond’s  Atlas  of  the  blood  in 
children was published, which used wintrobe’s classification and 
described  the  principal  anemia  of  infancy  under  the  title  “iron 
deficiency anemia” 59
In  1959,  Ingram  and  Stretton  postulated  two   classes  of 
thalassemia , α and β thalassemia, corresponding to α and β chain 
variants of the Hemoglobinopathies.
EPIDEMIOLOGY
 Anemia  is  a  global  health  problem  and  hypochromic 
microcytic  anemias  due  to  iron  deficiency  is  the  most  common 
nutritional disease prevalent in developing countries.
80 % of children in developing countries and 20% of children 
in developed countries are anemic according to MARTIN PL et al8 
.Prevalence of anemia in children is 51% and girls had a higher 
prevalence of anemias in another study9 Nearly the  half  of  well 
nourished children are anemic (47.6%9). 
The NFHS survey II (1998-99) estimated the prevalence of 
anemia  as 74% among children aged 6 months-3 years and severe 
anemia as 1.3%.(Hb <7 gm/dl).10
Kapoor   D  et  al  and  padmanaban  A et  al   estimated  the 
incidence  of  anemia  in  children  at  64%  and  37.9-45.1% 
respectively11,12.
El  hazimi  et  al  13 estimated  the  prevalence  of  anemia  in 
children as 24.8%.
In infants and children the most common cause of anemia is 
micro cytic  hypo chromic anemia,accounting for  55.4 – 64% of 
total anemias9,14,15. The prevalence of iron deficiency anemia in the 
United States ranges from 3 to 10 percent and may be as high as 30 
percent in low-income populations
Azmath manzoor et al & Osk et al put the prevalence  of iron 
deficiency  anemia  among  total  anemias  at  62.9  %  and  10% 
respectively12,13.
D Viswanath et al and Alukh  et al revealed that 89% and 
64% of  children  with  Microcytic  hypochromic  anemia  had  Iron 
Deficiency anemia.15,16. 
Prevalence  of  thalassemia  is  among  communities  of 
Punjabis,sindhis,gujaratis  and parsis. India  has  an estimated four 
crore thalassemia carriers and 10,000 thalassemia major children 
are born in India every year.
 Prevalence of thalassemia in general population varies from 
2.7% in Mumbai,5.5% in Delhi,and 10.4% in kolkata.  17. Incidence 
of  Thalassemia  minor  and  Thalassemia  major  among  anemic 
children varies from 14.34% to 4.7%.
A recent  study  of  Saradha  Sidhu  (1996)  on prevalence  of 
anemia  among  scheduled  caste  preschool  children,  reported  a 
prevalence rate of 55%. 57
As per ICMR study (V.P Choundhry et al in 1995), it  has 
been estimated that over 60% of rural children between 1 to 3 years 
have anemia and 40% of children between 3 to 6 years are anemic 
and iron deficiency was proved to be the commonest cause. 56
A prevalence of 60% was reported in children less than 4 years in a 
study conducted in 331 Filipino children between 9 months to 7 
years  by  Marzan et  al.  a  strong  association  was found between 
anemia and nutritional status.
ERYTHROPOEISIS
              The primitive erythropoeisis arises in the blood islands of 
the extraembryonic yolksac and shifts to the splancno-pleural/aorta-
gonad  mesonephros  of  the  developing  embryo.  Production  then 
shifts  to  liver  and  spleen  by  about  the  seventh  month  of 
gestation.Bone  marrow  replaces  the  liver  and  spleen  as  the 
principal site of production after birth.
              In new born, hematopoeitic tissue fills all cavities within  
the bones and with increasing age it becomes localized to cavities 
of upper shaft of femur,humerus the pelvis ,spine,skull and bones 
of thorax.
DEVELOPMENT OF BLOOD CELLS
               Blood cells develop from a small population of toti-potent 
hematopoeitic  stem  cells  which  give  rise  to  hematopoeitic  cell 
series.
Red cells are produced by proliferation and differentiation of 
precursors whose dominant representatives in the bone marrow are 
the erythroblasts. 
             During  the  course  of  differentiation,  the  size  of 
erythroblasts progressively decreases and the character of nucleus 
and cytoplasm changes as the cells proceed toward the point where 
proliferative capacity is lost and hemoglobin becomes the dominant 
protein in the cytoplasm. 
                The PRO-ERTHROBLAST is the least mature  of the  
morphologically identifiable members of the erythroid series. It has 
a  diameter  of  14-20 microns  and a  basically  round outline  with 
minor peripheral protuberances. Nucleus is large, round with fine 
chromatin, several nucleoli and basophilic cytoplasm. 
 Proerythroblast gives rise to basophilic erythroblast, a round cell 
with  diameter  of  12-16  microns  and  more  basophilic  cytoplasm 
than the pro-erythroblast.  The nucleus occupies a relatively large 
proportion  of  the  cell  having  coarser  and  more  basophilic 
chromatin strands. 
Next stage is represented by the polychromatic erythroblast, a 
round  cell  measuring  12-14  microns.  The  characteristic 
polychromatic  appearance  of  the  cytoplasm is  derived  from the 
mixture  of  the  basophilic  RNA  and  acidophilic  hemoglobin. 
Nuclear  chromatin  is  in  coarse,  deeply  basophilic  clumps. 
Proliferative  activity  ceases  at  this  stage.  Hemoglobin  which  is 
found in the  cytoplasm possibly  gains entrance into the  nucleus 
through pores in the nuclear membrane.,and after reaching a critical 
concentration in the nucleus (20gm/dl) reacts with nucleohistones, 
thereby  bringing  about  chromosomal  inactivation  and  nuclear 
condensation.1-3
              Orthochromatic erythroblasts are the last cells of nucleated  
red  cell  series.   They  measure  8-12  microns  with  a  small  and 
pyknotic  nucleus  with  a  homogenous  blue-black  appearance. 
Active  hemoglobin  synthesis  occurs  in  the  cytoplasm  ,which 
contains mitochondria and ribosomes.
Nucleus is extruded from the orthochromatic erythroblast and 
reticulocytes are formed with diffuse basophilic hue of cytoplasm. 
Reticulocytes have the same biconcave discoid shape as mature red 
cells with slightly greater volume and diameter.
Reticulocytes  enter  the  circulation  and  lose  their 
mitochondria and ribosomes over a course of few days and evolve 
into mature RBCs.
 STRUCTURE AND METABOLISM OF RED CELLS
Erythrocytes  are  biconcave  disc  shaped  cells  with  a  mean 
diameter  of  7.2-7.9  microns.  They  normally  lack  nuclei  and 
cytoplasmic structures such as lysosomes, endoplasmic reticulum 
and mitochondria. They exist in large blood vessels as biconcave 
discs,  but  change  their  shape  to  parachute  like  conformation  in 
small capillaries with diameter less than that of red cell.
The membrane of the RBC is a highly deformable, but non-
expansile or contractile structure. It’s integrity is firmly maintained 
by the attachment of it’s inner surface to a lattice like structure of 
specialized cytoskeletal proteins which supports the membrane and 
dictates the shape of the erythrocyte.
The major  protein component  of the membrane is band 3 
protein  which  spans  the  full  width  of  membrane  and  encases 
channels which facilitates transport of glucose and anions. 
Another important transmembrane protein is glycophorin .
The exterior surface of this molecule is heavily substituted 
with sugars containing sialic acid which contributes to the negative 
charge of the outer surface of red cell at physiological pH.
Glycolipids  in  the  outer  leaflet  of  membrane  contain  specific 
oligosaccharide sequences which constitute the ABO blood group 
substances.  Phospholipid  and  cholesterol  are  the  dominant  lipid 
components of the matrix of the membrane.
The  most  important  constituent  of  the  cytoskeleton  is  the 
protein  SPECTRIN.   Inter  twined  spectrin  molecules  are  linked 
together  by  a  specific  protein  and  action  to  form  a  lattice  like 
network which is attached to the inner surface of the membrane. 
This network is a resilient structure which normally causes red cells 
to resume the biconcave disc form after forces causing distortion 
are removed.
Specific sites on spectrin serves as points of attachment to 
molecules that protrude from the membrane (band 4.1 protein) and 
to the protein ankyrin which links the spectrin to the internal pole 
of the band 3 protein. 
Hemoglobin
Hemoglobin molecules  consist  of  two pairs  of  polypeptide 
globin chains. Each globin chain bears a haem group whose central 
iron atom is the site at which oxygen attaches to hemoglobin.
The type of globin chain synthesized by erythroid precursors 
undergoes progressive change with time after conception .
 The embryonic (Hb Gower 1 & 2), predominate until third 
month of gestation after which fetal Hb becomes the major form. 
HbF is the primary hemoglobin found in the fetus.Fetal hemoglobin 
consists of two ά and γ globin chains. It has a higher affinity for 
oxygen than adult  hemoglobin,  thus  increasing the  efficiency of 
oxygen transfer to the fetus. The relative quantities of HbF rapidly 
decrease to trace levels by the age of six to 12 months and are 
ultimately replaced by the adult forms, HbA and HbA2.
Adult  Hemoglobin  consists  of  two  ά  and  two  β  globin 
chains.Significant  amount  of  adult   hemoglobin  is  synthesized 
during  third  trimester  of  gestation.  The  proportion  of  adult  Hb 
progressively  increases  to  25% of  total  hemoglobin  at  birth,and 
about  97%  12  months  later.  Another  minor  form  of  adult 
hemoglobin is HbA2 which is made up of two ά and two δ globin 
chains.It is present only in trace amounts in the fetus and does not 
exceed 2% of total hemoglobin in normal adults. 
CLASSIFICATION OF ANEMIA 7
Anemias are classified on the basis of red cell morphology as 
microcytic  hypochromic,  normocytic  normochromic  and 
macrocytic anemias. The main advantage of classification is it  is 
simple, based on readily available red cell indices and forces the 
physicians to consider the most important types of curable anemia 
such as iron deficiency anemia, and anemia due to vitamin B12 and 
folic acid deficiency.
Such practical considerations has led to the wide acceptance 
of this classification.
Microcytic hypo chromic anemia.
RBC are smaller in size with exaggerated central pallor.  The 
MCV is  less  than 75 fl  and MCH less  than 24 pg respectively. 
Causes of hypochromic microcytic anemia
1) Iron deficiency
2) Thalassemia
3) Variant hemoglobin
4) Anemia of chronic disease
5) Sideroblastic anemia
6) Chronic lead and aluminium toxicity
7) Copper deficiency
Normo cytic normo chromic anemias.
The  RBC have  normal  size  and  Hemoglobinization  in  the 
blood films. MCV, MCH are within normal limits. Causes are red 
cell membrane defect, enzyme defects, acquired hemolytic anemias 
due to anti bodies, microangiopathic hemolytic anemias , acute red 
cell loss, hyper splenism and chronic kidney disease.
Macro cytic anemia 
The RBC are larger in size and lack central pallor.
MCV , MCH increased and MCHC is with in normal limits .
Common  causes  are  Vitamin  B12  and  Folic  acid  deficiency, 
Aplastic  anemias,  Hypothyroidism,  Liver  disease,  Bone  marrow 
infiltration.
DEFINITION OF ANEMIA
There  are  various  definitions  for  anemia.  A  functional 
definition of  anemia is  a  state  in  which,  the  circulating red cell 
mass is insufficient to meet the oxygen requirement of the tissues.
G.C. De Gruchy defined anemia as, a reduction in the concentration 
of hemoglobin in the peripheral blood below the normal for age and 
sex of the patient.58
Maxwell  M.  Wintrobe  described  anemia  as  decrease  in 
concentration of oxygen carrying substance in a certain volume of 
blood. 61
A  working  or  clinically  useful  definition  is  reduction  in 
concentration  of  Hb  per  unit  volume  of  blood  of  two  standard 
deviations below the normal for that population, age and sex. 59
Such  a  precise  definition  is  essential  because  the  symptoms  of 
anemia  are  often  non  specific  and  can  be  misinterpreted  as 
symptoms of emotional, cardiovascular or respiratory disorder and 
the reference values vary for different groups of population.
WHO definition of Anemia: WHO expert group4 proposed that 
anemia should be considered to exist when Hb is below 11 grams% 
in children aged 6 months to 6 years and 12 gms % in children aged 
6-12 years. Severity of the anemia can be graded as 
Mild anemia – 10-11gms5,  
Moderate anemia – 7-10gms%, 
Severe anemia < 7gms %6   
IRON DEFICIENCY ANEMIA
Anemia in the developing world is most commonly caused by 
an iron deficiency, which affects up to 50 percent of the population 
in  some  countries.  Estimates  suggest  that  over  one  third  of  the 
world’s  population  suffers  from  anemia,  mostly  iron  deficiency 
anemia.
 India continues to be one of the countries with very high 
prevalence. National Family Health Survey (NFHS-3) reveals the 
prevalence of anemia to be 70-80% in children, 70% in pregnant 
women and 24% in adult men.
 Prevalence of anemia in India is high because of low dietary 
intake, poor availability of iron and chronic blood loss due to hook 
worm  infestation  and  malaria.  While  anemia  has  well  known 
adverse  effects  on  physical  and  cognitive  performance  of 
individuals, the true toll of iron deficiency anemia lies in the ill-
effects  on  maternal  and  fetal  health.  Poor  nutritional  status  and 
anemia  in  pregnancy  have  consequences  that  extend  over 
generations.
The most common cause of Microcytic  hypochromic anemia 
is Iron Deficiency anemia.
For normal iron balance 1 mg of iron must be absorbed from 
diet everyday.Iron deficiency anemias can result from dietary lack 
of  iron,  Impaired  absorption,  increased  requirement  and  chronic 
blood loss.
In  developing countries  helminthic  infestations,malaria  and 
malnutrition are also common causal factors.20
In  developed  countries  introduction  of  unmodified  cow’s 
milk and defective absorption are also implicated. 21,22,23.
Three stages are discussed in IDA;
A)First  stage characterized by decreased storage of  iron without 
any detected abnormalities.
B)An intermediate stage of latent iron deficiency in which anemia 
has not occurred yet but iron stores are exhausted.
C)Third stage is overt iron deficiency when there is a decrease in 
concentration of Hb due to impaired  Hb synthesis.
As Iron deficiency progresses morphological changes in rbcs 
follow development of anemias.  The production of hypochromic 
microcytic rbcs is primarily attributed to delay in  the synthesis of 
Hemoglobin. 
During  erythropoeisis  Hb   enters  the  nucleus  and  it  reaches  a 
critical concentration in the  nucleus and reacts with nucleohistones 
causing nuclear condensation and chromosomal inactivation.
Microcytic cells are produced in iron deficiency because it  takes 
longer  to  reach  the  critical  hemoglobin  concentration  and  the 
generation  time  is  unaffected.Hence  more  cell  divisions  occur 
before nuclear inactivation and the resulting cell is small1,2,3.  
Impaired  red  cell  production  occurs  in  association  with  chronic 
diseases  like  osteomyelitis,  lung  abscess,rheumatoid  arthritis, 
bacterial  endocarditis   which  closely  resembles  Iron  deficiency 
anemia.
In these conditions there is some impediment in the transfer 
of  iron  from  the  storage  pool  to  the  erythroid  precursors.  In 
addition,  marrow  erythroid  progenitors  do  not  proliferate 
adequately  because  erythropoeitin  levels  are  inappropriately  low 
for the degree of anemia.
The reduction in renal erthropoeitin generation is attributed to 
production of IL-1,tumor necrosis factor(TNF) and interferon-γ .
These cytokines also inhibit  the release of iron from the storage 
pool.
The anemia is usually mild and the dominant symptoms are 
those  of  the  underlying  disease.  The  red  blood  cells  can  be 
normocytic and normochromic or hypochromic and microcytic as 
in  anemia  of  iron  deficiency.  Presence  of  low  serum  iron  and 
reduced total  iron-binding capacity  in  association  with  abundant 
stored iron in the mononuclear phagocytic cells are the common 
features.
Thalassemias are the most common single gene disorder in 
the  world  and  represent  a  major  health  burden  world  wide. 
Approximately 3% of the worlds population are carriers of a beta 
thalassaemia  mutation 19.  In  1925  Thomas  Cooley  & Pearl  Lee 
described a form of severe anemia occurring in children of Italian 
origin which was associated with splenomegaly and characteristic 
bone changes. 24 
Because  all  early  cases  were  reported  in  children  of 
Mediterranean  origin,  the  disease  was  later  termed  Thalassemia 
from  the  Greek  word  for  sea,  “thalassa”.65 The  first  case  of  β 
Thalassemia in India was reported by Dr.Mukerjee from Calcutta in 
1938. 18
Thalassemias are a large and heterogeneous group of red cell 
disorders  resulting  from  impaired  or  absent  synthesis  of  globin 
chains.  The  different  globin  chains  are  coded  for  on  either 
chromosome 16 (alpha) or 11 (Beta, delta & gamma chains). Thus, 
alpha  globin  synthesis  is  reduced  in  alpha  thalassemia  and beta 
globin synthesis in beta thalassemia,  alpha and beta synthesis in 
alpha-beta thalassemia,  and so forth.  In some contexts  it  is  also 
useful to sub classify the syndromes according to whether synthesis 
of  the  affected  globin  chain  is  totally  absent  (i.e.,  beta(-) 
thalassemia) or only partially reduced (i.e., beta (+) thalassemia).
Over 250 million people in the world and around 20 million 
in India carry the gene for beta thalassemia .One lakh children are 
born  world  over  every  year  with  the  homozygous  state  for 
thalassemia,  8000-10,000  children  of  whom are  born  in  India.18 
Frequency  of  thalassemia  trait  varies  from  3-17%  in  different 
populations.
The thalassemias are all  caused by mutations in the globin 
gene cluster.  The defects  are numerous,(more than 200 different 
mutations  have  been described19) and include  deletional  or  non-
deletional mutations. Mutations affect every step in the pathway of 
globin  gene  expression;  transcriptions,  processing  of  the  mRNA 
precursor,  translation  of  mature  mRNA  and  post  translational 
integrity  of  the  β  poly  peptide  chain.  Mutations  usually  have  a 
geographic  and  ethnic  distribution.  They  are  inherited  in  a 
multitude  of  genetic  combinations which are  responsible  for  the 
heterogeneous  group  of  clinical  syndromes.  Beta-thalassemia 
major,  also  known  as  Cooley’s  anemia  or  homozygous  beta-
thalassemia, is a clinically severe disorder due to inheritance   of 
two beta-thalassemia alleles, one on each copy of chromosome11. 
HbF  levels  are  elevated  in  beta-thalassemia.  The  diagnosis  of 
homozygous state is usually   clinically and by Hb F estimation.
The  term  beta-thalassemia  intermedia  is  applied  to  a  less 
severe clinical phenotype in which significant anemia occurs but 
chronic transfusion therapy is not absolutely required. It is usually 
due to inheritance of two beta-thalassemia mutations, one mild and 
one severe or inheritance of two mild mutations.
Thalassemia minor, also known as beta-thalassemia trait or 
heterozygous beta-thalassemia, is due to the presence of a single 
beta thalassemia mutation and a normal beta globin gene on the 
other  chromosome.  It  is  characterized  by  profound  microcytosis 
with hypochromia but mild or minimal anemia.
β Thalassemia Minor (Thalassemia Trait)
Inheritance  of  a  single  beta  thalassemia  allele  results  in  a 
mild  hypochromic  microcytic  anemia.  Individuals  are 
asymptomatic with mild or absent anemia.24  The hemoglobin level 
averages 1 or 2g/dL lower than that seen in   normal persons of the 
same age and sex. Elevations in Hb A2 and Hb F occur during the 
early years of life. Hb F levels decline more slowly than normal; 
the  diagnostic  elevated Hb A2 levels  are  established by about  6 
months of age. Strong intrafamilial correlations of both Hb A2 and 
mean corpuscular volume  (MCV) are noted.26 Osmotic fragility is 
decreased due to the presence of target  cells that resist hemolysis.27 
The  red  cell  count  is  increased  or  normal.  The  red  cells  are 
characteristically  hypochromic  (mean  corpuscular  hemoglobin 
[MCH] <26-27pg) and microcytic  (MCV <75-77 fl).  The  smear 
shows varying number of target cells, poikilocytes, ovalocytes and 
basophilic  stippling.  The reticulocyte count  is  normal or slightly 
elevated. Red cell survival is normal, iron utilization is decreased, 
and slight ineffective erythropoiesis is present.  Most patients are 
asymptomatic.
     During pregnancy the anemia of thalassemia trait often 
becomes more severe, and transfusions are sometimes necessary.24 
Microcytic  anemia  refractory  to  iron  therapy    should  always 
suggest the possibility of thalassemia trait. . In many instances, iron 
deficiency  anemia  is  erroneously  diagnosed  and  iron  therapy  is 
given   without significant improvement.
            Although a variety of indices calculated from blood count  
parameters have been suggested to differentiate thalassemia from 
iron deficiency, each has some degree of inaccuracy; most are no 
better than the MCV alone. In general, the MCV is rarely >75fl and 
hematocrit  <30  in  beta  thalassemia  trait.  In  iron  deficiency,  the 
hematocrit usually falls to <30 before the MCV falls to <80fl. Free 
erythrocyte porphyrin levels are normal in thalassemia trait but are 
elevated  in  iron  deficiency.  Direct  tests  for  iron  deficiency  are 
preferable for correct diagnosis.
The diagnosis of beta-thalassemia trait is established in most 
instances by the demonstration of altered proportions of Hb A2. The 
level of Hb A2 in beta- thalassemia trait averages 5.1% (range 3.5-
7.0%), approximately twice the normal level (1.5-3.5%); the 
Hb A2/HbA1 ratio is 1:20 instead of the normal 1:40. This increase 
is probably due to a post-translational (assembly) phenomenon with 
increased  opportunity  for  alpha-chains  to  combine  with  alpha-
chains   in the face of beta-chain deficiency. If concomitant severe 
iron-deficiency anemia occurs, Hb A2 levels may fall, sometimes 
into the normal range.28
Two mechanisms are proposed in pathogenesis of anemia in 
thalassemias.The  deficit  in  HbA  synthesis  produces  under-
hemoglobinised  hypochromic  microcytic  red  cells.Another 
important  factor  is  diminished  red  cell  survival  because  of  cell 
membrane damage due to insoluble inclusions of free alpha chains.
The  inclusion  bearing  erythroid  precursors  are  prone  to 
intramedullary death and escaping red cells are killed by splenic 
sequestration and destruction.
Alpha-thalassemia is caused by deficient synthesis of alpha-
chain which is encoded by pair of genes on chromosome16.
Reduced  synthesis  of  alpha  chain  is  due  to  deletions  of  alpha-
globin genes. 
In  newborn  with  αthalassemia  excess  unimpaired  γglobin 
chains forms γ4 known as Hb-Barts.In adults,excess β-globin chains 
form HbH,which precipitates in oxidized form in older red cells 
which are then removed by splenic macrophages.
In  sideroblastic  anemias,there  is  decreased  production  of 
protoporphyrin  or  impaired  incorporation  of  iron  into 
protoporphyrin  in  the  erythroid  cells.This  results  in  insufficient 
heme generation and excess iron accumulation in the marrow.
Patients have excess body iron and serum ferritin and hypochromic 
microcytes in the peripheral smear .For confirmation bone marrow 
examination is needed which will show ringed sideroblasts.
APPROACH TO MICROCYTIC ANEMIA
In  children  common  causes  of  microcytic  hypochromic 
anemia are Iron deficiency anemia,Thalassemia and rarely anemia 
of chronic disease.
Lead poisoning, sideroblastic anemias cause microcytosis but 
are rare in children.Iron deficiency anemia  is most common cause 
of Microcytic hypochromic anemia.33,34.
Reticulocyte  count  is  decreased  in  Iron  deficiency  anemia 
and  Anemia  of  chronic  disease  and  it  is  increased  in  α  or  β 
thalassemia or HbE disease.
RBC count is elevated in (>5 million/cumm) in children with 
Thalassemia trait  and depressed in children with Iron deficiency 
anemia..
In Thalassemia minor cases the microcytosis is severe than 
might be expected for the degree of anemia.
Target  cells  and  basophilic  stippling  tend  to  be  more 
prominent in thalassemia than Iron deficiency anemia..
Modification  of  mentzer  index can be  used to  differentiate  Iron 
deficiency anemia and Thalassemia Trait35 which is based on MCV 
and RBC count.
MCV/RBC count >14 –suggestive of Iron Deficiency anemia
MCV/RBC count<12- suggestive of Thalassemia trait disorders.
Red  cell  distribution  width  (RDW)  is  a  useful  parameter  to 
differentiate  Iron  deficiency  anemia  from  other  causes.RDW 
measures  the  anisocytosis  derived  from  erythrocyte  volume 
distribution.36,37,38
Anisocytosis is an early and prominent finding in IDA and is 
the first parameter to rise even before appearance of anemia.
An increased Red cell distribution width(RDW) appears to be 
90-100% sensitive for Iron deficiency and 50-70% specific.39
Increase in red cell distribution width  correlates with severity 
of Iron Deficiency anemia.
In a study mean RDW value was 16.6±1.78, 17.95±1.91, and 
20.55±1.32 among mild,moderate and severe anemic children.40
Homozygous  hemoglobinopathies  HbE  and  HbC  tend  to  be 
microcytic and normochromic and many target cells are apparent in 
blood smear.41,42,
Homozygous  β  thalassemia  cases  show  extreme 
anisopoikilocytosis and nucleated rbcs and target cells in peripheral 
smear apart from signs of hemolysis and ineffective erythrpoeisis.
A therapeutic trial of oral iron is an appropriate initial diagnostic 
test  for  microcytic  anemias  with  features  suggestive  of  Iron 
Deficiency anemia in Peripheral smear and automated hemogram.31
Further investigation is necessary only if there is no response to 
treatment.
A dose of 6mg/kg/day of elemental iron given in the form of 
oral ferrous sulfate is the preferred method.31,
Reticulocyte  count  should  increase  in  5-10  days  and  the 
serum Hb should increase by 1gm/dl/week thereafter.
Poor  response  is  due  to  factors  like  poor  compliance,poor 
absorption ,incorrect diagnosis and ongoing blood loss.
Further  lab  analysis  is  needed  in  children  who  are  not 
responding to rule out other causes.
Tests  for  screening  Iron  deficiency  Anemia  are  Serum 
iron,TIBC,serum ferritin and free erythrocyte protoporphyrin.
Serum  Iron levels are measurement of Iron bound to transferrin.
Total iron binding capacity (TIBC) is an indirect measurement of 
transferring in terms of amount of iron it will bind.
Serum  Iron has considerable fluctuation in values 43,44,45,46 of 
individual upto 10-40% within a single day or from day to day.47,48
TIBC values show only slight variation.
Normal serum iron-70-200 µgm/dl.
TIBC value-250-435µg/dl.
Transferrin saturation is 20-45% normally.
Values below 16% are noted in Iron Deficiency  and Anemia 
of chronic disease.TIBC is often increased in Iron Deficiency and 
decreased in Anemia of chronic disease.49
Determination of  serum  ferritin often the only test needed to 
diagnose Iron Deficiency anemia.Serum  ferritin concentrations is 
proportional  to  total  body iron stores  and are  not  influenced by 
recent iron therapy.50
Ferritin  values-10-500  µg/l  Sr  ferritin  is  low  in  Iron 
Deficiency anemia,(10µgm/L) ,normal in thalassemia and high in 
Anemia  of  chronic  disease.51Sr  ferritin  can  be  elevated  in 
infection,inflammation  or  malignancy  as  it  is  an  acute  phase 
reactant.52
Free  Erthrocyte  protoporphyrin(FEP)  is   accumulated  in 
RBCs  when  iron  is  unavailable  or  unable  to  combine  with 
protoporphyrin  to  form  heme.It  is  useful  in  differentiating  Iron 
deficiency anemia(Elevated FEP) from thalassemia minor(normal 
FEP)60
Evaluation  of  bonemarrow  iron  stores  is  used  much  less 
nowadays.
In  Bone  marrow  aspirates  ,hemosiderin  appears  as  blue 
granules in Prussian blue staining.61.
Normal  marrow  iron  is  graded  1+  to  3+.In  IDA,marrow 
hemosiderin is absent .in ACD,iron is present with grade2-3.Iron 
stores  are  greatly  increased  in  thalassemia  major(5+--6+).Hb 
electrophoresis  should  be  obtained  in  patients  with  microcytosis 
and target cells with normal serum ferritin levels .
Β-thalassemia  major  children  have  elevated  HbF  levels 
ranging from10-90% and HbA2 levels may be normal or elevated,
(5-7%)Hb A2 is elevated in heterozygous carriers of βThalassemia 
varying from 3.5-7%.62.Thalassemia trait causes microcytosis with 
mild anemia and Hb electrophoresis reveal HbBarts(γ4 tetramers) 
in new born period.
In  HbH disease  electrophoresis  shows  HbH-25%,Hb Barts 
and low normal levels of HbA2.
HEMOGLOBIN A2
Measurement of Hemoglobin A2 (confirmatory test for beta 
thalassemia trait) is expensive and time consuming.
Raised hemoglobin A2 level is the gold standard for diagnosis 
of  thalassemia  trait.  HbA2 levels  can  be  measured  by  various 
methods such as microcolumn chromatography, high performance 
liquid  chromatography  (HPLC)  and  capillary  isoelectrofocusing. 
Subjects with HbA2 levels of 3.5 per cent and above are considered 
to have thalassemic trait.
                Hb A2 levels measured should be interpreted as given in 
the table below. (30)
INTERPRETATION OF Hb A2 RESULTS
HbA2 range
(%)
Interpretation
> 7.0%
Hb A2 values of >7.0 % are extremely rare.
Exclude a structural variant.
Repeat Hb A2 estimation.
Rare beta thalassemia mutations
3.8-7.0% Beta thalassemia trait
 Unstable hemoglobin
3.4-3.7%
Severe iron deficiency in Beta Thalassemia trait.
Additional  delta-chain  variant  with  beta  thalassemia 
trait 
Interaction of alpha(-) and beta thalassemia
Rare Beta thalassemia mutations
Presence  of  Hb  S,  making  accurate  measurement 
difficult
Interaction of alpha thalassemia and Hb S.
Analytical error (repeat analysis).
2.0-3.3% Normal.
δ-β thalassemia (if Hb F elevated).
Rare cases of β thalassemia trait, including co-existing 
β (-) and  δ  thalassemia  and  coexisting  β  and  α 
thalassemia.
α thalassemia 
      <2.0%
δ-beta thalassemia (if Hb F elevated)
α thalassemia trait
Hb H disease.
Additional   δ- chain variant present 
AIMS & OBJECTIVES
To study the clinical profile of hypochromic microcytic 
anemia in children aged 2 months to 12 years attending the 
OPD  at  Institute  of  Child  Health  &  Research  Centre, 
Government Rajaji Hospital, Madurai.
To evaluate the role of therapeutic oral iron therapy as an 
diagnostic  approach to hypochromic microcytic anemia
MATERIALS AND METHODS
Study population:
Children  attending  inpatient  and  outpatient  services  at 
Institute of Child Health and Research Centre, Government Rajaji 
Hospital, Madurai.
Study group:
A total number of 350 cases of anemia were studied  from 
both inpatient  and outpatient services  in the age group 2 months to 
12  years  in  the  Institute  of  Child  Health  and  Research  Centre, 
Government Rajaji Hospital, Madurai 
Study period:
January 2008 to June 2009
Study design:
Prospective interventional study
Collaborating department:
Department  of  pathology,  Government  Rajaji  Hospital, 
Madurai.
Inclusion criteria:
The criteria used in the selection of children was those whose 
hemoglobin less than 11 gm% in age group less than 6 years and 
whose hemoglobin less than 12 gm% in age group 6 to 12 years 
along  with  peripheral  smear  showing  hypochromic  microcytic 
anemia.
Exclusion criteria:
This  study  had  excluded  the  cases,  who  were  already 
diagnosed  elsewhere  or  who  were  on  treatment  prior  to 
hospitalisation  or  peripheral  smear  showing  macrocytic  and 
normochromic normocytic anemia or the neonates.
Ethics committee approval was obtained
Methodology:
Informed consent was obtained from all parents. All the 350 
cases  of  anemia  were  studied  by  taking  detailed  history  and 
thorough  clinical  examination  with  meticulous  care  and  the 
findings were recorded in the predesigned proforma annexed in the 
last few pages.  Hemoglobin estimation and peripheral smear study 
were done in all cases.
All children in the study group of more than one year of age 
and  those  with  less  than  one  year  of  age  with  no  hepato 
splenomegaly or frontal bossing were dewormed by giving a single 
dose of Albendazole and were started on oral Iron therapy.
Albendazole was given in a dose of 400mg for children  more 
than 2 years of age and 200 mg for children less than 2 years of 
age. Oral iron preparations used in this study was Ferrous sulphate. 
Each ferrous sulphate tablet containing an elemental iron of 20 mg. 
Iron was prescribed at a dose of 3-6mg/kg/day in 2-3 divided doses. 
Drugs  were  given  once  in  2  weeks.   During  each  visit  these 
children  were  followed  up  by  Hb  estimation  and  checked  for 
compliance.
At  the end of  3  months completion of  iron therapy repeat 
peripheral  smear  examination was done.   Those cases  improved 
with  iron  that  is  peripheral  smear  showing  normochromic 
normocytic  type  of  RBC’s  were  considered  as  Iron  deficiency 
anemia  and  they  were  prescribed  iron  for  one  more  month  to 
replenish the stores and then iron therapy  stopped.  Those cases not 
improved  with  iron  were  further  evaluated  using  automated 
hemogram,   Hb  Electrophoresis  and  bone  marrow  study  as 
necessary based on individual cases.
All  children  less  than  1  year  of  age  with  severe  pallor, 
hepatosplenomegaly  and  frontal  bossing  were  not  given  iron 
therapy. These children were evaluated using automated hemogram 
and Hb electrophoresis.  Bone marrow study was done if necessary.
1. Hb Estimation :
Hb is  estimated by using Sahli’s  hemoglobinometer.   It  is 
based on the separation of globin from haemoglobin by treatment 
with hydrochloric acid to produce acid hematin which is measured 
by calorimetry.
0.1N Hcl is placed in a graduated tube (Wintrobe’s) up to 20th 
mark. Blood is withdrawn upto 20th mark (20ml) in Sahli’s pipette 
and added to the tube; mixture is allowed to stand for 10 min for 
complete conversion of acid hematin. The solution is diluted with a 
few drops of distilled water of a time until colour change matches 
the standard.  The height of solution corresponds to the Hb content.
2)  Peripheral blood smear :
Blood  smears  were  prepared  on  glass  slides  by  wedge 
method.  A drop of capillary blood is placed in the middle of the 
slide about 1 to 2 cm from one end.  A second spreading slide is 
placed at 30 to 45 angle and moved forward. Smears are dried and 
stained by Leishman’s stain containing Eosin as acidic stain and the 
methylene blue as the basic stain.
Pour 8-12 drops of Leishman’s stain over the slide and wait 
for two minutes.  Then add double the volume of buffer water and 
wait for 8-10 minutes.  Then the wash the slide in running water for 
2-3 seconds.  Wipe off the excess stain from under surface of the 
slide  and  air  dry  smear.   Then  smear  is  examined  under  the 
microscope.
3.  Hemoglobin Electrophoresis :
In this study, high pressure liquid chromatography was used. 
3ml of blood added with EDTA solution was used. With HPLC the 
Hb fractions are separated based on their ionic interactions with the 
cationic  column  under  high  pressure  and  by  elution  with  two 
phosphate buffers differencing in pH and ionic strength.  The result 
is a chromotagram with a percentage of each Hb fraction.
4. Automated blood cell counter :
2 ml  of  blood was collected by Venepuncture  into  bottles 
containing EDTA solution and transported to laboratory.
In  this  study,  COULTER Ac  T.  DIFF  TM Analysis  SUN 
Diagnostics type of cell counts was used.  It uses the principle of 
electrical impendence.  It measures Hb, MCV, MCHC, RDW, RBC 
count, WBC count and platelet count.
5.  Bone marrow Aspiration cytology :
Bone marrow is a semifluid and easily aspirated through a 18 
gauge size bone marrow needle.  It is usually taken from posterior 
iliac  crest  or  upper  end  of  tibia.   Smears  are  stained  with 
Leishman’s stain and assessed for cellularity, Maturation patterns 
of  erythroid  and  myeloid  series  and  the  presence  of 
megakaryocytes.
Statistical Analysis :
The  information  collected  regarding  all  the  selected  cases 
were recorded in a master chart.  Data analysis was done with the 
help of computer using Epidemiological Information Package (EPI 
2008).
Using this software frequencies, percentage, mean, standard 
deviation, chi square and ‘p’values are calculated. Kruskul Wallis 
chisquare  test  was  used  to  test  the  significance  of  differences 
between  quantitative  variables  and  Yate’s  test  for  qualitative 
variables.  A ‘p’ value less than 0.05 is taken to denote significant 
relationship.
OBSERVATION, ANALYSIS AND RESULTS
In this study a total of 400 children were included. 350 cases turned 
up for regular follow up. 50 cases lost the follow up.
Table – 1
Incidence of Anemia in relation to Sex
Sex Cases
No. %
Male 205 58.6
Female 145 41.4
Total 350 100
Out of 350 children in the study group, 205 (58.6%) were 
males and 145 (41.4%) were females.
Table – 2
Severity of Anemia 
S.No. Degree of 
anemia
No. %
1. Severe
(<7 mg%)
142 40.6
2 Moderate
(7-9.9gm%)
188 53.7
3 Mild
(10-10.9gm%)
20 5.7
Of the above analysis, 142 cases  of severe anemia, 188 cases 
of moderate anemia and 20 cases of mild anemia were documented. 
Since this is a hospital based study number of moderate to severe 
anemia cases are more.
Table – 3
Relationship between Sex and Severity of Anemia
Degree of anemia
Sex
Male Female Total
Mild (10 – 10.9 mg%) 9 11 20
Moderate (7.9 – 9 mg%) 114 74 188
Severe (< 7 mg%) 82 60 142
Total 205 145 350
‘p’  =  0.5364  (not  significant).   There  is  no  statistically 
significant  difference in the relationship between sex and severity 
of anemia.
                           
Table – 4
Age Distribution 
Age group No. %
Less than 1 year 15 4.3
1 – 3 yrs 126 36
3.1 – 6 yrs 106 30.3
6.1 – 12 yrs 103 29.4
Total 350 100
Range
Mean
SD
Months – 12 years
4.4 years
3.2 yrs
Of the above analysis, 15 cases were less than 1 year of age, 
126 case were between 1-3 year of age,  106 cases were between 3-
6 years of age, 103 cases were between 6-12 years of age.
The mean age of this study is 4.4 years.
Table – 5
Complaints
Complaints No. %
Easy fatiguability 339 96.9
Pica 66 18.9
Passing worms in stools 9 2.6
Fever 340 97.1
Breathlessness 21 3.1
The various modes of presentation of anemia were as follow. 
331 cases had easy fatiguability.  66 cases had H/o pica, 9 cases 
had H/o passage of worms in stools, 340 cases had fever and 11 
cases presented with breathelessness.  Many cases had more than 
one complaints.
Table – 6
Signs 
Signs No. %
Pallor 350 100
Koilonychia 47 13.4
Frontal bossing 10 2.9
Pedal edema 1 0.3
Hepatomegaly 69 19.7
Splenomegaly 68 19.4
In   this  study,  the  various  findings  among  children 
with  anemia  were  as  follows.   Pallor  was  present  in  almost  all 
cases. Koilonychia in 47 cases, frontal bossing in 10 cases.  Pedal 
edema in 1 case.  Hepatomegaly in 69 cases and splenomegaly in 
68 cases. Many cases had more than one signs.
Table – 7
Splenomegaly and type of Anemia
Type of Anemia Splenomegaly 
Mild < 4 cm Moderate 
4 to 7 cm
Massive
> 7 cm
IDA 51 0 0
Others 5 10 2
In this study, splenomegaly was present in 68 cases (19.4%) 
Out of 68 cases, 51 cases (14.8%) of IDA had mild splenomegaly. 
Remaining 17 cases belongs to Thalassemia group. Among them 5 
cases had mild splenomegaly. 10 cases had moderate splenomegaly 
and 2 case had massive splenomegaly.
Table – 8
Hb % 
Hb% Range Mean SD
Initial Hb 3.2   -  10.5 7.36 1.31
Repeat Hb 5.4 – 12.8 11.8 0.79
Increase in Hb 0 – 8 4.4 1.4
% of increase 0 – 250 64.5 32.3
From the above analysis, the mean Hb% at the time of entry 
to study was 7.36gms%.  The mean Hb% after the iron therapy was 
11.8 gms%.  The mean increase in Hb was 4.4 gms%.
Table – 9
RBC Count
RBC count
Range
Mean
SD
1.45 – 4.33
2.9
0.61
           In this study, the average RBC count was 2.9 million cells / 
cumm.
Table – 10
Response to Iron
Response to Iron
Cases
No. %
Positive 333 95.1
Negative 7 2
Iron not given 10 2.9%
Total 350 100
In this study, 333 cases improved with oral iron therapy, 7 
cases not improved with iron and 10 cases does not received iron 
therapy.
Table – 11
Diagnosis
Diagnosis
Cases
No. %
Iron deficiency anemic 333 95.1
Others - total
        Alpha Thalassemia
        Thalassemia intermedia
        Thalassemia major
        Thalassemia trait
        Hb variant E
        Unstable 
            Haemoglobinopathy
17
2
1
7
5
1
1
4.9
0.6
0.3
2.0
1.4
0.3
0.3
Total 350 100
From the above analysis, Iron deficiency anemia is the major 
cause which constitutes about 95% (333cases).  The other causes 
were 7 cases of Thalassemia major,  5 case of Thalassemia trait; 
thalassemia intermedia one case; Hb variant E one case; unstable 
hemoglobinopathy One case and alpha thalasemia two cases.
B :  Relationship between Type of anaemia and other variables
Table – 12
Age and type of anemia
Type of Anemia Age in years
Mean SD
I DA 4.53 3.22
Others 2.69 2.26
P 0.0107
Significant
From the above analysis the mean age of IDA was 4.58 yrs 
and in remaining other causes  the mean age was 2.69 with a ‘p’ 
value of   0.0107
Thus the age of presentation of different type of anemia is 
statistically significant.
Table – 13
Type of Anemia
Sex
Type of Anemia
IDA Others
No. % No %
Male 194 94.6 11 5.4
Female 139 95.9 6 4.1
‘p’ 0. 7841 Not significant
Among  the  205  males,  194  were  IDA and  11  were  other 
types.  Among the 145 females, 139 were IDA and 6 were other 
types.
P – 0.07841.  The relationship between the  type of anemia 
and sex are not statistically significant.
Table – 14
Type of Anaemia and Hb% changes
Hb
Type of Anaemia
‘p’
IDA Others
Mean SD Mean SD
Initial Hb 7.42 1.29 6.12 1.12 0.0001 
significant
Repeat Hb 11.89 0.41 7.7 2.29 0.001 
significant
Increase 4.46 1.34 1.81 1.97 0.0012 
significant
% of increase 65.2 31.9 30.6 34 0.0028 
significant
From the above analysis, in case of IDA, the mean rise in Hb
% after oral iron therapy was 4.46gm% whereas in  the other types 
the mean rise in Hb% was only 1.81%
Thus the type of anemia and Hb% changes after  oral  iron 
therapy were  statistically significant.
C :  Relationship between Response to Iron and other factors
Table – 15
Age and response to iron
Response to Iron Age in years
Mean SD
Positive 4.49 3.23
Negative 4.57 2.21
P 0.5331
Not significant
From  the  above  analysis,  the  mean  age  of  the  children 
responded to oral iron was 4.49 years and those not responded was 
4.57 years.
P – 0.5339.
Thus the age group and response to iron is not statistically 
significant.
Table – 16
Type of Anemia and Response to Iron
Type of 
Anemia
Response to Iron
Positive Negative Not given
No. % No. % No. %
IDA 333 100 0 0 0 0
 Others
(17) 0 0 7 41.2 10 10
‘p’ 0.0001 significant
From the above analysis, it is seen that all cases of IDA, 333 
cases improved with iron and among the other types of anemia  7 
cases not improved and 10 cases were not started on  iron therapy.
P - 0.0001
Thus the relation between type of anemia and responds to 
iron is statistically significant.
Table – 17
Sex and Response to Iron
Hb
Response to Iron
Positive Negative
No. % No. SD
Male 196 97.5 5 2.5
Female 140 98.6 2 1.4
‘p’ 0.3883 Not significant
From the above analysis, 196 males improved with iron and 5 
cases not improved.  Among the females 140 cases improved with 
iron and 2 cases not improved.
P =  0. 3883
There is no statistically significant  relation between sex and 
response to iron.
Table – 18
Response to Iron and Hb% changes
Parameters
Response to Iron
‘p’
Positive Negative
Mean SD Mean SD
Initial Hb 7.4 1.3 6.68 0.87 0.118 not 
significant
Repeat Hb 11.87 0.53 7.75 1.16 0.0006 
significant
Increase 4.45 1.35 1.45 0.21 0.0012 
significant
% of increase 65.15 32 23.12 1.91 0.003 
significant
From the  above analysis,  the  mean rise   in  Hb% in cases 
improved with iron was 4.45gm% whereas only 1.45%,  in cases 
with no response to iron therapy.
Thus the response to iron and rise in Hb% are statistically 
significant.
DISCUSSION
The clinical profile of hypochromic microcytic anemia such 
as  age  and  sex  distribution,  the  presenting  complaints,  clinical 
findings, degree of anemia, various etiological factors, importance 
of oral iron therapy as a diagnostic test,  using higher investigations 
only when necessary were analysed and discussed here.
Sex :
In  this  study,  the  incidence  of  hypochromic  microcytic 
anemia is  more  common in males (58.6%) than female  children 
(41.4%).  But  this  is  not  statistically  significant.   This  is  in 
accordance  with  the  fact  that  sex  plays  important  role  in 
determining prevalence only in older age group.
Age :  In this study, 4.3% are less than one year of age.  36% 
are between  1- 3 years of age. 30.3% are between 3 -6 years of age 
and 29.41 are between 6-12 years of age.  
Thus the most common age group affected is in between 1-3 
years of age.
This is similar to Omprakash et al study which states that the 
peak incidence of nutritional anemia in children occurs between 6 
months to 3 years of age.
Presenting Complaints :
In  this  study,  the  presenting  complaints  of  hypochromic 
microcytic  anemia  includes  easy  fatiguability  (96.9%),  Pica  in 
18.9%,  worm  infestation  in  2.6%,  fever  in  97.1%  and 
breathlessness in 3.1%.
Fever is the most common presenting complaints. Since this 
is a hospital based study, most of the cases who came for upper 
respiratory tract infection and viral fever are incidentally found to 
be anemic and included in the study.  Hence fever is present in 
majority of cases.
Out  of  350  cases,  339  cases  have  the  compliant  of  easy 
fatiguability.  This confirms the observation in western literature 
that  easy fatiguability  is  the most  common symptoms in anemia 
particularly Iron deficiency anemia.
In  this  study  PICA  is  present  in  66  cases  (18.9%).  This 
symptom is found in 50% children in a  study conducted by Crosby 
et al.
Worm infestation is present only in 2.6% of cases.  The low 
prevalence  of  parasitism  in  this  study  may  be  because  of  wide 
spread use of antihelminithic drugs by health officials.
Signs :
In this study, Pallor is present in all cases.  Out of 350 cases, 
47 cases (13.4%) have koilonychias.  2.9% of cases have frontal 
bossing.   Malar prominence along with frontal  bossing are even 
present in severe iron deficiency anemia
Hepatomegaly  is  present  in  69  cases  (19.7%)  and 
splenomegaly  is  present  in  68  cases  (19.4%)  .In  this  study 
hepatosplenomegaly is seen in 14.8% of the cases of IDA. Mild 
degree  of  hepato  splenomegaly  is  present  in  iron  deficiency 
anemia.
Piyush Gupta and OPGhai states that Spleen is enlarged in 
15% of cases of IDA.
OmPrakash  et  al  states  that  mild  degree  of  hepato 
splenomegaly is not uncommon in IDA.
In this study, the mean initial Hb% is 7.36gm%.  The mean 
Hb% after oral iron therapy is 11.8gms%
Iron  deficiency  anemia  is  the  most  common  cause  of 
Nutritional  anemia  world  wide.  It  is  the  most  common  type  of 
hypochromic microcytia anemia.
In country like India, Iron deficiency anemia co exists with 
almost every type of others anemia in children. Hence it has to be 
corrected to come for  final diagnosis.
In  this  study,  all  cases  of  hypochromic  microcytic  anemia 
are  given  Oral  iron  in  the  form  of  ferrous  sulphate  tablets 
containing 20 mg elemental iron  at a dose of 3-6 mg / kg / day in 
2-3 divided doses. 
Oral  iron therapy is given for 3 months.   At the end of 3 
months,  cases  improved  with  iron  are  those  with  true  iron 
deficiency  anemias.   Only  those  cases  not  improved  with  iron 
therapy are further investigated.
The  above  approach  is  supported  by  Hermiston  et  al,  the 
pediatric clinics of North America. It states that “In hypochromic 
microcytic anemia, therapeutic trial of oral iron is an appropriate 
initial diagnostic test.  Further investigation is unnecessary unless 
there is no response.  A dose of 6 mg / kg / day of elemental iron 
divide  bid  to  tid  is  indicated.   Ferrous  sulphate  is  the  most 
bioavailable preparation.
Thalassemia is the next most common cause of hypochromic 
microcytic anemia.  It is an inherited genetic disorder causing real 
burden to the family and the society.  Thalassemia trait cases have 
to  be  detected  to  prevent  future  homogenous  thalassemia  major 
cases.  Hb electrophoresis is the investigation of choice.  If there is 
coexisted  iron  deficiency  in  thalaseemia  trait  case,  even  by  Hb 
electrophoresis it cannot be detected.It has to be corrected prior to 
Hb electrophoresis.
This emphasizes once again that oral iron has to be given to 
all cases of hypochromic microcytic anemia as done in this study.
This concept is supported by Hermiston et al. The pediatrics 
clinics  of  North  America  that  the  patient  should  not  be  iron 
deficient at the time of electrophoresis as iron deficiency depresses 
delta globin synthesis, obscuring a rise in HbA2.
Wintrobe’s  Hematology  states  that  the  diagnosis  of 
heterozygous  beta  thalassemia  rests  on  the  demonstration  of  an 
increase in HbA2 or HbF is an individual whose peripheral blood 
smear shows microcytosis, hypochromia, target cells and basophilic 
stippling.
Iron  deficiency  causes  reduced  levels  of  HbA2.  Elevated 
levels cannot be demonstrated until the iron deficiency is corrected.
Nelson  states  that  thalassemia  trait  is  frequently 
misdiagnosed as iron deficiency in children. A short course of iron 
and reevaluation is all that is required to identify children who will 
need further evaluation
In this study, out of 350 cases, 333 cases are Iron deficiency 
anemia (95.1%)
The most common cause of hypochromic microcytic anemia 
in this study is Iron deficiency anemia.  This finding is similar to 
the studies conducted by Viswanath D et al  where the incidence is 
89%.
Another  study  by  Fazal  Razir  Khan  et  al  states  that  the 
incidene is 92% and by Kapoor D et al it is 88%.
As per ICMR study (VP Choundhry et al in 1995) on anemia. 
Iron deficiency was proved to be the commonest cause.
Out of 350 cases, 142 cases (40.6%) were severe anemia, 188 
cases  (53.7%) were  moderate  anemia and 20 cases (5.7%) were 
mild anemia.  Since this  is  a  hospital  based study.  Moderate  to 
severe anaemia are more than the mild anemia cases.
Out  of  350  cases,  7  cases  did  not  improve  with  oral  iron 
therapy.   These  cases  were  further  evaluated  by  automated 
hemogram and Hb electrophoresis.
Automated  hemogram  was  done  in  all  these  7  cases  to 
demonstrate low MCV ( less than 75fl) even after 3 months iron 
therapy. Automated hemogram was done to confirm the findings on 
peripheral smear.
Out  of  7  cases,   5  cases  of  thalassemia  trait  (1.4%)  was 
detected by  Hb electrophoresis. All the 5 cases  showed elevated 
HbA2 .
One case of Thalassemia intermedia was detected.  He is an 8 
year old boy presented with pallor, mild hepatosplenomegaly and 
did  not  improve  with  3  months  of  oral  iron  therapy.   Hb 
electrophoresis showed raised HbF, raised HbA2 and low HbA.
The remaining one case was Hb variant E.  She is a 7 year old 
girl  presented with pallor,  liver enlarged 2cm below right  costal 
margin, and spleen enlarged 4cm below left costal margin, did not 
improve with oral iron. Hb electrophoresis showed low HbA and 
raised HbE, normal HbA2.
In this study, out of 350 cases, 10 cases have not received 
iron.   These  children  typically  presented  with  severe  pallor, 
hepatosplenomegaly and many were in the  age group of  less than 
one year. Hb electrophoresis was done for these cases without prior 
oral iron therapy.
Among the 10 cases, 7 cases are diagnosed as Thalassemia 
major.  It showed elevated HbF and low HbA.
One case of unstable hemoglobinopathy was diagnosed. He is 
a  1  year  old  boy  presented  with  severe  pallor,  fever  and 
hepatosplenomegaly. Peripheral smear showed severe hypochromic 
microcytic anemia.  Hb electrophoresis showed decreased  HbA, 
Normal  HbA2,  HbF  not  elevated  and  unidentified  Peak  was 
present.  Child became more  pallor  and sick during intercurrent 
illness and was symptomatically treated.  In between the illness the 
boy was normal without pallor.
Of the remaining 2 cases,  one was that of a 4 months old 
female child and another that of a  7 months old female child both 
of whom presented with severe pallor and  hepato splenomegaly. 
Peripheral smear showed  Severe hypochromic microcytic anemia.. 
Hb  electrophoresis  were   normal  in  both  cases.   Both  were 
subjected to bone marrow smear study.  In both cases erythroid 
hyperplasia  were  seen.   These  2  cases  could  be  that  of  Alpha 
thalassemia. Hb electrophoresis by HPLC method could not detect 
alpha thalassemia.  Genetic studies are further required to confirm 
the diagnosis.
In  this  study,  the  incidence  of  Thalassemia  (including 
Thalassemia major, intermedia and trait) is 4%.
World wide, the frequency of thalassemia varies from 3-17% 
in  different  population.   In  a  study  by  Salma  Shaikh  et  al  the 
incidence of thalassemia is 11%.
CONCLUSION
1. The  most  common  cause  of  hypochromic  microcytic 
anemia in children is  Iron deficiency anemia ( nutritional 
anemia )
2. Thalassemia group is the next common cause
3. Children in 1-3 years of age are commonly affected
4. Fever  and  easy  fatiguability  are  the  major  presenting 
features.
5. Mild hepatosplenomegaly and frontal bossing can occur in 
Iron deficiency anemia.
6. A therapeutic trial of oral iron is an appropriate initial step 
in  the  diagnostic  approach  of  hypochromic  microcytic 
anemia.
7. Costly  investigations  like  Hb  electrophoresis  and  bone 
marrow study are required only in selected cases.
LIMITATIONS
 Though measures were taken to  increase the follow up of 
cases with hypochromic microcytic  anemia the dropout 
was 12.5 % 
 Causes  of  hypochromic  microcytic  anemia  such  as 
sideroblastic anemia and lead poisoning are not made out. 
RECOMMENDATIONS
Cases  with  hypochromic  microcytic  anemia  should  be 
given a trial of therapeutic oral iron therapy before subjecting 
them to Hb electrophoresis as iron deficiency depresses  delta 
globin synthesis, obscuring a rise in HbA2.   
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PROFORMA
CASE NO:
Height: 
Weight:
Blood Group:               Rh: 
+  / -  
NAME:
AGE:                   SEX: 
Male/Female
ADDRESS:                         
PHONE NO:
FATHERS NAME: MOTHERS NAME:
Occupation: Family Income:
community Consanguinous:
No. of Brothers: No. of Sisters:
COMPLAINTS YES NO DURATION
Easy fatiguability
Fever 
Recurrent   Cough  / 
Cold
Shortness of Breath
Irritability 
Picca
PAST HISTORY YES NO DURATION
H/o Jaundice
H/o Blood transfusion
H/o Drug (Iron) intake
H/o Sibling death
H/o  Family  member 
taking  Blood 
transfusion
H/o Passing worms in 
stools
Diet Veg / Non. Veg
                                        
                                 
CLINICAL FEATURES
GENERAL EXAMINATION:
VITAL SIGNS             T                     RR                        PR                     BP
PALLOR LN ENLARGEMENT
CLUBBING CYANOSIS
ICTERUS PEDAL EDEMA
FRONTAL BOSSING KOILONYCHIA
RESPIRATORY SYSTEM CARDIOVASCULAR SYSTEM:
TRACHEA HEART SOUNDS                 :
AIR ENTRY MURMURS                           :
ADDED SOUNDS IF YES DESCRIBE               :
ABDOMEN CNS
DISTENSION / TENDERNESS CRANIAL NERVES
ORGANOMEGALY MOTOR SYSTEM
MASS / FREE FLUID SENSORY SYSTEM
Investigations
Hb        -
Blood group                -
Peripheral smear        -
Complete Hemogram   -
Automated hemogram  -
Hb electrophoresis     -
Bone marrow study   - 
LIST OF ABBREVIATIONS
IDA  –  IRON DEFICIENCY ANEMIA
Hb  – HEMOGLOBIN
MCV – MEAN CORPUSCULAR VOLUME
MCHC – MEANCORPUSCULARHEMOGLOBIN 
CONCENTRATION
MCH – MEAN CORPUSCULAR HEMOGLOBIN
RDW – RED CELL DISTRIBUTION WIDTH
RBC – RED BLOOD CELL
WBC  – WHITE BLOOD CELL
EDTA  – ETHYLENE DIAMINE ACETIC ACID
WHO – WORLD HEALTH ORGANISATION
NFHS – NATIONAL FAMILY HEALTH SURVEY
HC,MC  –  HYPOCHROMIC MICROCYTIC
NC,NC – NORMOCHROMIC NORMOCYTIC
Dl  – DECILITRE
fl – FEMTOLITRE
µg  –  MICROGRAM
PS  – PERIPHERAL SMEAR
HPLC  – HIGH PRESSURE LIQUID 
CHROMATOGRAPHY
Hcl  – HYDROCHLORIC ACID
SD  – STANDARD DEVIATION
α  – ALPHA
β  – BETA
EC  – ELONGATED CELLS
TC  – TARGET CELLS
OPD  – OUT PATIENT DEPARTMENT
TI - THALASSEMIA INTERMEDIA
TT - THALASSEMIA TRAIT
TM - THALASSEMIA MAJOR
UH - UNSTABLE HEMOGLOBINOPATHY
AT - ALPHA THALASSEMIA
HBE - HEMOGLOBIN VARIANT E
P - POSITIVE
N - NEGATIVE
M - MALE
F - FEMALE


